Town centre ‘Man Van’ prostate cancer checks boost diagnosis – research
A ‘Man Van’ mobile testing unit was sent to target at-risk groups in London, working with local hospitals and community ...
Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
The Abu Dhabi Investment Authority is boosting its share in private markets
The government-run investor increased allocations last year to private equity and credit amid a global slowdown in dealmaking ...